Supplemental Tables S1-S3 from VEGF-A Expression Correlates with <i>TP53</i> Mutations in Non–Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy

Supplemental Tables S1-S3. Number/Frequency of mutations in 123 patients with lung cancer (S1); List of genes used in transcriptomic analysis (S2); Expression levels of VEGF-A in mutated (M) vs. wild-type (WT) TP53 lung cancer by histology (S3).